ENTA
Enanta Pharmaceuticals, Inc.
ENTA offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
UNH
UnitedHealth Group Incorporated
UNH has the edge over ENTA overall, supported by lower modeled downside and stronger modeled upside.
ENTA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Under pressure | |
| Strong |
ENTA's balance sheet is currently strong, and its revenue is stable, but its profitability and cash flow are under pressure.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
ENTA PE Valuation
ENTA has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
ENTA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Decline | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect ENTA's losses to shrink, with revenue declining.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
UNH has the edge over ENTA on the outlook, with more favorable revenue expectations.
ENTA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$2.42 | +$1.90 |
| Q1 2026 | -$2.60 | +$1.94 |
| Q4 2025 | -$3.21 | +$1.74 |
| Q3 2025 | -$3.84 | +$1.64 |
| Q2 2025 | -$4.32 | +$1.14 |
| Q1 2025 | -$4.54 | +$1.71 |
| Q4 2024 | -$4.95 | +$1.62 |
| Q3 2024 | -$5.48 | +$0.90 |
ENTA is still losing money, but far less than before: $2.42 per share over the past year, against $6.57 at its worst in late 2023.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH has the edge over ENTA on earnings quality, reporting a profit while its opponent remains loss making.
ENTA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $14.4M | -22% |
| Q1 2026 | $17.2M | +15% |
| Q4 2025 | $18.6M | +9.8% |
| Q3 2025 | $15.1M | +3.5% |
| Q2 2025 | $18.3M | +1.9% |
| Q1 2025 | $14.9M | -12% |
| Q4 2024 | $17M | -5.8% |
| Q3 2024 | $14.6M | -23% |
ENTA's revenue fell from its 2019 peak and has held roughly level since: $14M last quarter, down 22% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -120% | -17 points |
| Q1 2026 | -69% | +95 points |
| Q4 2025 | -60% | +78 points |
| Q3 2025 | -122% | +83 points |
| Q2 2025 | -103% | +31 points |
| Q1 2025 | -164% | +28 points |
| Q4 2024 | -139% | +55 points |
| Q3 2024 | -204% | -41 points |
ENTA's operating margin was −120% last quarter, down 17 points from the same quarter a year ago.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH has the edge over ENTA on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH has the edge over ENTA on profitability, with a higher operating margin.
ENTA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$10M | -158% |
| Q1 2026 | -$7.2M | +$8.9M |
| Q4 2025 | -$11.8M | +$13.7M |
| Q3 2025 | -$7.9M | +$11.4M |
| Q2 2025 | $17.4M | +$38.7M |
| Q1 2025 | -$16M | +$14.2M |
| Q4 2024 | -$25.5M | +$229K |
| Q3 2024 | -$19.4M | +$3.6M |
ENTA has burned cash in almost every quarter: −$37M over the past year, against −$44M the year before.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over ENTA on cash generation, producing positive trailing cash flow while its opponent burns cash.
ENTA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +50K shares |
| 1 year | +36% | +7.7M shares |
| 3 years | +40% | +8.4M shares |
| 5 years | +45% | +9.1M shares |
ENTA has 29M diluted shares, up 36% from a year ago.
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has the edge over ENTA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
ENTA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2020 | -5.0x | Net Cash |
| Q4 2019 | -1.1x | Net Cash |
| Q3 2019 | -1.3x | Net Cash |
ENTA has more cash than debt.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
ENTA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.1 | Neutral |
| Stochastic | 14.2 | Oversold |
ENTA's weekly RSI is 43 (neutral) and its Stochastic is 14 (oversold).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
ENTA PE vs Healthcare Sector
| Metric | ENTA | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
ENTA has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
ENTA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $11.6 | 3.6% below |
| 20 week MA | $12.7 | 12% below |
| 50 week MA | $13.3 | 15% below |
| 100 week MA | $10.4 | 7.8% above |
| 200 week MA | $14.5 | 23% below |
ENTA's trend is mixed: it's above one of its five weekly moving averages, and 23% below its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over ENTA on trend strength, trading above more of its moving averages.
ENTA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $62.5 | $42.9 | -31% |
| 2021 | $42.9 | $76.4 | +78% |
| 2022 | $76.4 | $47.1 | -38% |
| 2023 | $47.1 | $9.41 | -80% |
| 2024 | $9.41 | $6.01 | -36% |
| 2025 | $6.01 | $16.9 | +180% |
| 2026 YTD | $16.9 | $11.2 | -34% |
ENTA's yearly returns have swung widely, from +180% in 2025 to −80% in 2023. It's down 34% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over ENTA on returns for 2026, with the stronger performance.